Journal of Korean Neurosurgical Society

  • 제63권3호
  • /
  • Pages.380-385
  • /
  • 2020
  • /
  • 2005-3711(pISSN)
  • /
  • 1598-7876(eISSN)
대한신경외과학회 (The Korean Neurosurgical Society)
권호 표지
DOI QR코드

DOI QR Code

In-Vitro Study of Urokinase Thrombolysis Following Stereotactic Aspiration of Intracerebral Hematoma

  • Son, Wonsoo (Department of Neurosurgery, School of Medicine, Kyungpook National University) ;
  • Park, Jaechan (Department of Neurosurgery, School of Medicine, Kyungpook National University) ;
  • Kang, Dong-Hun (Department of Neurosurgery, School of Medicine, Kyungpook National University) ;
  • Han, Young-Min (Department of Neurosurgery, School of Medicine, Kyungpook National University) ;
  • Choi, Yeon-Ju (Department of Neurosurgery, School of Medicine, Kyungpook National University) ;
  • Ohk, Boram (Department of Clinical Trial Center, Kyungpook National University Hospital)
  • 투고 : 2018.12.05
  • 심사 : 2019.05.18
  • 발행 : 2020.05.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : A consensus regarding the ideal regimen for urokinase (UK) thrombolysis subsequent to stereotactic spontaneous intracerebral hemorrhage aspiration has yet to be established. The purpose of this study is to evaluate the efficacy of UK thrombolysis relative to when the regimen is changed. Methods : Venous blood from 30 heathy volunteers was obtained for this in-vitro study. Various concentrations of UK solution were added to microcentrifuge tubes containing the clotted blood. The efficacy of UK thrombolysis was identified by checking the weight of lysed hematoma following various time intervals with different concentrations of UK solution. Group one, the "3×4" group involved four administrations every 3 hours over 12 hours, and group two, the "6×2" group involved two administrations every 6 hours over 12 hours. Results : More hematoma was lysed in the 3×4 group than the 6×2 group across all concentration levels (however, the differences were only significant between groups at the 500 and 1000 IU concentration levels, p<0.05). There were no significant differences of lysed hematoma among the various UK solution concentrations within groups. Conclusion : This study suggests that frequent administrations of UK thrombolysis may result in a greater degree of lysed hematoma in comparison to a higher concentration of UK.

키워드

참고문헌

  1. Aydin IH, Takci E, Kadioglu HH, Kayaoglu CR, Tuzun Y : The effect of urokinase on experimental intracerebral haematomas. Zentralbl Neurochir 55 : 29-34, 1994
  2. Chang YH, Hwang SK : Frameless stereotactic aspiration for spontaneous intracerebral hemorrhage and subsequent fibrinolysis using urokinase. J Cerebrovasc Endovasc Neurosurg 16 : 5-10, 2014 https://doi.org/10.7461/jcen.2014.16.1.5
  3. Chen X, Chen W, Ma A, Wu X, Zheng J, Yu X, et al. : Frameless stereotactic aspiration and subsequent fibrinolytic therapy for the treatment of spontaneous intracerebral haemorrhage. Br J Neurosurg 25 : 369-375, 2011 https://doi.org/10.3109/02688697.2010.520765
  4. Gaberel T, Macrez R, Gauberti M, Montagne A, Hebert M, Petersen KU, et al. : Immunotherapy blocking the tissue plasminogen activatordependent activation of N-methyl-D-aspartate glutamate receptors improves hemorrhagic stroke outcome. Neuropharmacology 67 : 267-271, 2013 https://doi.org/10.1016/j.neuropharm.2012.11.023
  5. Gaberel T, Montagne A, Lesept F, Gauberti M, Lemarchand E, Orset C, et al. : Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis. Neuropharmacology 85 : 158-165, 2014 https://doi.org/10.1016/j.neuropharm.2014.05.001
  6. Keric N, Maier GS, Samadani U, Kallenberg K, Dechent P, Brueck W, et al. : Tissue plasminogen activator induced delayed edema in experimental porcine intracranial hemorrhage: reduction with plasminogen activator inhibitor-1 administration. Transl Stroke Res 3 : 88-93, 2012 https://doi.org/10.1007/s12975-012-0188-3
  7. Lian L, Xu F, Hu Q, Liang Q, Zhu W, Kang H, et al. : No exacerbation of perihematomal edema with intraclot urokinase in patients with spontaneous intracerebral hemorrhage. Acta Neurochir (Wien) 156 : 1735-1744, 2014 https://doi.org/10.1007/s00701-014-2130-9
  8. Lippitz BE, Mayfrank L, Spetzger U, Warnke JP, Bertalanffy H, Gilsbach JM : Lysis of basal ganglia haematoma with recombinant tissue plasminogen activator (rtPA) after stereotactic aspiration: initial results. Acta Neurochir (Wien) 127 : 157-160, 1994 https://doi.org/10.1007/BF01808759
  9. Meunier JM, Wenker E, Lindsell CJ, Shaw GJ : Individual lytic efficacy of recombinant tissue plasminogen activator in an in vitro human clot model: rate of "nonresponse". Acad Emerg Med 20 : 449-455, 2013 https://doi.org/10.1111/acem.12133
  10. Montes JM, Wong JH, Fayad PB, Awad IA : Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience. Stroke 31 : 834-840, 2000 https://doi.org/10.1161/01.str.31.4.834
  11. Narayan RK, Narayan TM, Katz DA, Kornblith PL, Murano G : Lysis of intracranial hematomas with urokinase in a rabbit model. J Neurosurg 62 : 580-586, 1985 https://doi.org/10.3171/jns.1985.62.4.0580
  12. Naval NS, Nyquist P, Carhuapoma JR : ICH aspiration and thrombolysis. J Neurol Sci 261 : 80-83, 2007 https://doi.org/10.1016/j.jns.2007.04.037
  13. Niizuma H, Otsuki T, Johkura H, Nakazato N, Suzuki J : CT-guided stereotactic aspiration of intracerebral hematoma--result of a hematomalysis method using urokinase. Appl Neurophysiol 48 : 427-430, 1985
  14. Ouriel K, Welch EL, Shortell CK, Geary K, Fiore WM, Cimino C : Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis. J Vasc Surg 22 : 593-597, 1995 https://doi.org/10.1016/S0741-5214(95)70045-5
  15. Prasad S, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF : Development of an in vitro model to study clot lysis activity of thrombolytic drugs. Thromb J 4 : 14, 2006
  16. Rohde V, Rohde I, Thiex R, Ince A, Jung A, Duckers G, et al. : Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg 97 : 954-962, 2002 https://doi.org/10.3171/jns.2002.97.4.0954
  17. Samadani U, Rohde V : A review of stereotaxy and lysis for intracranial hemorrhage. Neurosurg Rev 32 : 15-21; discussion 21-22, 2009 https://doi.org/10.1007/s10143-008-0175-z
  18. Tan Q, Chen Q, Niu Y, Feng Z, Li L, Tao Y, et al. : Urokinase, a promising candidate for fibrinolytic therapy for intracerebral hemorrhage. J Neurosurg 126 : 548-557, 2017 https://doi.org/10.3171/2016.1.JNS152287
  19. Teernstra OP, Evers SM, Lodder J, Leffers P, Franke CL, Blaauw G : Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 34 : 968-974, 2003 https://doi.org/10.1161/01.str.0000063367.52044.40
  20. Wang GQ, Li SQ, Huang YH, Zhang WW, Ruan WW, Qin JZ, et al. : Can minimally invasive puncture and drainage for hypertensive spontaneous Basal Ganglia intracerebral hemorrhage improve patient outcome: a prospective non-randomized comparative study. Mil Med Res 1 : 10, 2014 https://doi.org/10.1186/2054-9369-1-10
  21. Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C : Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology 35 : 159-162, 1993 https://doi.org/10.1007/BF00593977